These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Reactivation by novel pyridinium oximes of rat serum and skeletal muscle acetylcholinesterase inhibited by organophosphates. Bennett JP; Meek EC; Chambers JE J Biochem Mol Toxicol; 2024 Jul; 38(7):e23750. PubMed ID: 38952032 [TBL] [Abstract][Full Text] [Related]
10. In vitro P-glycoprotein activity does not completely explain in vivo efficacy of novel centrally effective oxime acetylcholinesterase reactivators. Dail MB; Meek EC; Chambers HW; Chambers JE Drug Chem Toxicol; 2019 Jul; 42(4):403-408. PubMed ID: 29722548 [TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of three novel pyridinium aldoxime acetylcholinesterase reactivators in female rats. Backer BS; Meek EC; Ross MK; Chambers JE Toxicol Appl Pharmacol; 2022 Jul; 446():116046. PubMed ID: 35550885 [TBL] [Abstract][Full Text] [Related]
12. Preclinical studies of noncharged oxime reactivators for organophosphate exposure. Okolotowicz KJ; Dwyer M; Smith E; Cashman JR J Biochem Mol Toxicol; 2014 Jan; 28(1):23-31. PubMed ID: 23943350 [TBL] [Abstract][Full Text] [Related]
13. Interactions between xylene-linked carbamoyl bis-pyridinium mono-oximes and organophosphates inhibited-AChE: a kinetic study. Sharma R; Gupta B; Acharya J; Kaushik MP; Ghosh KK Toxicology; 2014 Feb; 316():1-8. PubMed ID: 24345352 [TBL] [Abstract][Full Text] [Related]
15. Evaluating the broad-spectrum efficacy of the acetylcholinesterase oximes reactivators MMB4 DMS, HLö-7 DMS, and 2-PAM Cl against phorate oxon, sarin, and VX in the Hartley guinea pig. Wilhelm CM; Snider TH; Babin MC; Platoff GE; Jett DA; Yeung DT Neurotoxicology; 2018 Sep; 68():142-148. PubMed ID: 30056178 [TBL] [Abstract][Full Text] [Related]
16. Novel brain-penetrating oximes for reactivation of cholinesterase inhibited by sarin and VX surrogates. Chambers JE; Meek EC; Chambers HW Ann N Y Acad Sci; 2016 Jun; 1374(1):52-8. PubMed ID: 27153507 [TBL] [Abstract][Full Text] [Related]
17. The effect of PON1 enhancers on reducing acetylcholinesterase inhibition following organophosphate anticholinesterase exposure in rats. Meek EC; Chambers HW; Pringle RB; Chambers JE Toxicology; 2015 Oct; 336():79-83. PubMed ID: 26275814 [TBL] [Abstract][Full Text] [Related]
18. The in silico identification of novel broad-spectrum antidotes for poisoning by organophosphate anticholinesterases. Habiballah S; Chambers J; Meek E; Reisfeld B J Comput Aided Mol Des; 2023 Dec; 37(12):755-764. PubMed ID: 37796381 [TBL] [Abstract][Full Text] [Related]
19. In vitro and in silico Evaluation of Non-Quaternary Reactivators of AChE as Antidotes of Organophosphorus Poisoning - a New Hope or a Blind Alley? Soukup O; Korabecny J; Malinak D; Nepovimova E; Pham NL; Musilek K; Hrabinova M; Hepnarova V; Dolezal R; Pavek P; Jost P; Kobrlova T; Jankockova J; Gorecki L; Psotka M; Nguyen TD; Box K; Outhwaite B; Ceckova M; Sorf A; Jun D; Kuca K Med Chem; 2018; 14(3):281-292. PubMed ID: 29332594 [TBL] [Abstract][Full Text] [Related]
20. Oxime-mediated in vitro reactivation kinetic analysis of organophosphates-inhibited human and electric eel acetylcholinesterase. Sahu AK; Sharma R; Gupta B; Musilek K; Kuca K; Acharya J; Ghosh KK Toxicol Mech Methods; 2016 Jun; 26(5):319-26. PubMed ID: 27101948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]